Shishodia S, Aggarwal BB. 2004. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of igarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9. Cancer Research 64(14):5004-12. [NERC ID #24720]
de Andrade M, Ebbert JO, Wampfler JA, Miller DL, Marks RS, Croghan GA, Jatoi A, Finke EE, Sellers TA; Yang P. 2004. Environmental tobacco smoke exposure in women with lung cancer. Lung Cancer 43(2):127-34. [NERC ID #24733]
Kiyohara C, Wakai K, Mikami H, Sido K, Ando Ma, Ohno Y. 2003. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women. International Journal of Cancer 107(1):139-44. [NERC ID #24748]
Haugen A. 2002. Women who smoke: are women more susceptible to tobacco-induced lung cancer? Carcinogenesis 23(2):227-9. [NERC ID #24784]
Zheng T, Holford T R, Zahm S H, Owens P H, Zhang Y, Ali-Osman F. 2001. Tobacco smoking, GSTT1 genotype and breast cancer risk. American Journal of Epidemiology 153(11 Supplement):S205. [NERC ID #25666]
Sanchez-Cespedes M, Decker PA, Doffek KM, Esteller M, Westra WH, Alawi EA, Herman JG, Demeure MJ, Sidransky D, Ahrendt SA. 2001. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers. Cancer Res. 61(5):2092-2096. [NERC ID #26759]
Lee PN. 2001. Relation between exposure to asbestos and smoking jointly and the risk of lung cancer. Occup. Environ. Med. 58(3):145-153. [NERC ID #26765]
Lee PN. 2001. Lung Cancer and Type of Cigarette Smoked. Inhal Toxicol 13(11):95-76. [NERC ID #27715]
Hou SM, Falt S, Nyberg F, Pershagen G, Lambert B. 2001. Interaction between GSTT1 genotype and smoking on lung cancer risk. Chem-Biol Interact 133(1-3):106-108. [NERC ID #26747]
Hainaut P, Pfeifer GP. 2001. Patterns of p53 G.fwdarw.T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 22(3):367-374. [NERC ID #24332]
Hainaut P, Olivier M, Pfeifer GP. 2001. TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database. Mutagenesis 16(6):551-3; author reply 555-6. [NERC ID #24794]
Doll R. 2001. Commentary: Lung cancer and tobacco consumption. International Journal of Epidemiology 30(1):30-31. [NERC ID #25555]
Darby S, Whitley E, Doll R, Key T, Silcocks P. 2001. Diet, smoking and lung cancer: A case-control study of 1000 cases and 1500 controls in South-West England. Br. J. Cancer 84(5):728-735. [NERC ID #26749]
Chobanyan NS, Nersesyan AK. 2001. Re: metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. Journal of the National Cancer Institute. Journal of the National Cancer Institute 93(20):1575-7. [NERC ID #24795]
Boffetta P, Kreuzer M, Benhamou S, Agudo A, Wichmann HE, Gaborieau V, Simonato L. 2001. Risk of lung cancer from tobacco smoking among young women from Europe. International Journal of Cancer 91(5):745-6. [NERC ID #24331]
Anderson KE, Carmella SG, Ye M, Bliss RL, Le C, Murphy L, Hecht S. 2001. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. J. Natl. Cancer Inst. 93(5):378-381. [NERC ID #24805]
Sierra MS, Hoyos LS. 2000. Chromosome aberrations in peripheral blood lymphocytes among cigarette smokers in Colombia. Environmental and Molecular Mutagenesis 35(Suppl 31):55. [NERC ID #25326]
Sheppard BJ, Williams M, Plummer HK, Schuller HM. 2000. Activation of voltage-operated Ca2+-channels in human small cell lung carcinoma by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. International Journal of Oncology. 16(3):513-518. [NERC ID #25621]
Piipari R, Savela K, Nurminen T, Hukkanen J, Raunio H, Hakkola J, Mantyla T, Beaune P, Edwards RJ, Boobis AR, Anttila S. 2000. Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers. International Journal of Cancer 86(5):610-616. [NERC ID #25468]
Lee C-H, Ko Y-C, Goggins W, Huang J-J, Huang M-S, Kao E-L, Wang H-Z. 2000. Lifetime environmental exposure to tobacco smoke and primary lung cancer of non-smoking Taiwanese women. International Journal of Epidemiology 29(2):224-231. [NERC ID #25600]
Kreuzer M, Krauss M, Kreienbrock L, Joeckel K-H, Wichmann H-E. 2000. Environmental tobacco smoke and lung cancer: A case-control study in Germany. American Journal of Epidemiology 151(3):241-250. [NERC ID #25591]
Kim DH, Christiani DC, Wiencke JK, Nelson HH, Mark EW, Wain JC, Kelsey KT. 2000. Promoter methylation of p16INK4a may play a role in the development of squamous cell lung cancer in cigarette smokers. Proceedings of the American Association for Cancer Research Annual Meeting 41:496. [NERC ID #25422]
Johnson KC, Hu J, Mao Y. 2000. Lifetime workplace and residential exposure to environmental tobacco smoke and lung cancer in never-smoking women. American Journal Of Epidemiology 151(Suppl 11):S28. [NERC ID #25684]
Husgafvel-Pursiainen K, Jourenkova N, Kannio A, Boffetta P, Benhamou S. 2000. Female lung cancers: Histology, tobacco smoke exposure, and p53 mutations. Proceedings of the American Association for Cancer Research Annual Meeting 41:22. [NERC ID #25694]
Hou S-M, Ryberg D, Falt S, Deverill A, Tefre T, Borresen A-L, Haugen A, Lambert B. 2000. GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients. Carcinogenesis 21(1):49-54. [NERC ID #25004]
Hecht SS. 2000. Recent studies on tobacco smoke carcinogens. Abstracts of Papers American Chemical Society 219(1-2):TOXI 3. [NERC ID #25284]
Gamble JF, Nicolich MJ. 2000. Comparison of ambient PM risk with risks estimated from PM components of smoking and occupational exposures. J. Air Waste Manage. Assoc. Air and Waste Management Association Specialty Conference Charleston, SC, USA 19000125-19000128 Journal of the Air and Waste Management Association 50(8):1514-1531. [NERC ID #26810]
El-Zein R, Abdel-Rahman SZ, Conforti-Froes N, Alpard SK, Zwischenberger JB. 2000. Chromosome aberrations as a predictor of clinical outcome for smoking associated lung cancer. Cancer Lett. (Shannon, Irel.) 158(1):65-71. [NERC ID #26828]
Djordjevic MV, Stellman SD, Zang Edith. 2000. Doses of nicotine and lung carcinogens delivered to cigarette smokers. Journal of the National Cancer Institute (Bethesda) 92(2):106-111. [NERC ID #25193]
Conway K, Edmiston SN, Cui L, Pang J, Drouin S, Geradts J, Tse J, Millikan R, Newman B. 2000. The prevalence and spectrum of p53 mutations in the Carolina Breast Cancer Study suggests a role for cigarette smoking in breast cancer development. Proceedings of the American Association for Cancer Research Annual Meeting 41:222. [NERC ID #25414]
Colditz GA. 2000. Illnesses caused by smoking cigarettes. Cancer Causes & Control 11(1):93-97. [NERC ID #25253]
Chen C, Ricks S, Fitzgibbons D, Doody DR, Porter PL, Schwartz SM. 2000. Glutathione S-transferase M1 and T1 genotypes, cigarette smoking, and the risk of squamous cell cancer of the oral cavity. Proceedings of the American Association for Cancer Research Annual Meeting 41:593. [NERC ID #25409]
Caplan LS, Hall HI, Levine RS, Zhu K. 2000. Preventable risk factors for nasal cancer. Annals of Epidemiology 10(3):186-191. [NERC ID #25472]
Boffetta P, Tredaniel J, Greco A. 2000. Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: A meta-analysis. Environmental Health Perspectives 108(1):73-82. [NERC ID #25622]
Alawi EA, Decker PA, Doffek KM, Demeure MJ, Yang SC, Jen J, Sidransky D, Ahrendt SA. 2000. Cigarette smoking is strongly associated with mutation of the K-ras gene in primary adenocarcinoma of the lung. Proceedings of the American Association for Cancer Research Annual Meeting 41:294. [NERC ID #25410]
Ahrendt SA, Chow JT, Yang SC, Wu L, Zhang M-J, Jen J, Sidransky D. 2000. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Res 60(12):3155-3159. [NERC ID #26844]
Zhong L, Goldberg MS, Gao YT, Jin F. 1999. Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China. Epidemiology 10(5):488-94. [NERC ID #23751]
Zayas JG, Rubin BK, York EL, Lien DC, King M. 1999. Bronchial mucus properties in lung cancer: relationship with site of lesion. Can Respir J 6(3):246-52. [NERC ID #22794]
Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X. 1999. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91(2):151-6. [NERC ID #21038]
Yngveson A, Williams C, Hjerpe A, Lundeberg J, Soderkvist P, Pershagen G. 1999. p53 Mutations in lung cancer associated with residential radon exposure. Cancer Epidemiol Biomarkers Prev 8(5):433-8. [NERC ID #22797]
Yesner R. 1999. Re: 'Effect of cigarette smoking on major histological types of lung cancer' SA Khuder, HH Dayal, AB Mutgi et al., Lung Cancer 1998;22:15-21 [letter]. Lung Cancer 24(1):45. [NERC ID #23042]
Yang Q, Hergenhahn M, Weninger A, Bartsch H. 1999. Cigarette smoke induces direct DNA damage in the human B-lymphoid cell line Raji. Carcinogenesis (Oxford) 20(9):1769-1775. [NERC ID #23342]
Xu XC, Lee JS, Lee JJ, Morice RC, Liu X, Lippman SM, Hong WK, Lotan R. 1999. Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J Natl Cancer Inst 91(15):1317-21. [NERC ID #23783]
Xinarianos G, Scott FM, Liloglou T, Prime W, Callaghan J, Gosney JR, Field JK. 1999. Telomerase activity in non-small cell lung carcinomas correlates with smoking status. Int J Oncol 15(5):961-5. [NERC ID #23836]
Woodson K, Albanes D, Tangrea JA, Rautalahti M, Virtamo J, Taylor PR. 1999. Association between alcohol and lung cancer in the alpha-tocopherol, beta-carotene cancer prevention study in Finland. Cancer Causes & Control 10(3):219-226. [NERC ID #22947]
Wistuba II, Behrens C, Virmani AK, Milchgrub S, Syed S, Lam S, Mackay B,; Minna JD, Gazdar AF. 1999. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res 59(8):1973-9. [NERC ID #22554]
Wiencke JK, Thurston SW, Kelsey KT, Varkonyi A, Wain JC, Mark EJ, Christiani DC. 1999. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung [see comments]. J Natl Cancer Inst 91(7):614-9. [NERC ID #22470]
Wang YC, Lee HS, Chen SK, Chang YY, Chen CY. 1999. Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer 35(2):226-30. [NERC ID #22994]
Wang XD, Russell RM. 1999. Procarcinogenic and anticarcinogenic effects of beta-carotene. Nutr Rev 57(9 Pt 1):263-72. [NERC ID #23859]
Volm M, Koomagi R, Mattern J. 1999. Angiogenesis and cigarette smoking in squamous cell lung carcinomas: an immunohistochemical study of 28 cases. Anticancer Res 19(1A):333-6. [NERC ID #22519]
Volm M, Koomagi R. 1999. Association of cyclin D1 expression in lung cancer and the smoking habits of patients. Cancer Lett 141(1-2):147-50. [NERC ID #23041]
Vacchino MN. 1999. Poisson regression in mapping cancer mortality. Environ Res 81(1):1-17. [NERC ID #22748]
Tsukuma H, Tanaka H, Koyama Y, Kinoshita N, Koyama H, Furukawa H. 1999. [Descriptive and analytical epidemiology of second primaries in Osaka, Japan]. Gan To Kagaku Ryoho 26(13):1980-7. In Japanese, summary English. [NERC ID #23840]
Tseng JE, Rodriguez M, Ro J, Liu D, Hong WK, Mao L. 1999. Gender differences in p53 mutational status in small cell lung cancer. Cancer Res 59(22):5666-70. [NERC ID #23884]
Tseng JE, Kemp BL, Khuri FR, Kurie JM, Lee JS, Zhou X, Liu D, Hong WK, Mao L. 1999. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers. Cancer Res 59(19):4798-803. [NERC ID #23806]
Tousey PM, Wolfe KW, Mozeleski A, Mohr DL, Cantrell BB, O'Donnell M, Heath CW, Blot WJ. 1999. Determinants of the excessive rates of lung cancer in northeast Florida. South Med J 92(5):493-501. [NERC ID #22549]
Tomizawa Y, Adachi J, Kohno T, Hamada K, Saito R, Noguchi M, Matsuno Y, Hirohashi S, Yamaguchi N, Yokota J. 1999. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma. Clin Cancer Res 5(5):1139-46. [NERC ID #22866]
Tominaga K, Mori K, Yokoi K, Noda M, Goto N, Machida S, Nagai M. 1999. Lung cancer in patients under 50 years old. Jpn J Cancer Res 90(5):490-5. [NERC ID #22782]
To i Figueras J. 1999. [Tobacco and cancer: from epidemiological association to molecular evidence] Tabaco y cancer: de la asociacion epidemiologica a la evidencia molecular. Med Clin (Barc) 112(15):589-94. In Spanish. [NERC ID #23083]
Thompson LD, Wenig BM, Heffner DK, Gnepp DR. 1999. Exophytic and papillary squamous cell carcinomas of the larynx: A clinicopathologic series of 104 cases. Otolaryngol Head Neck Surg 120(5):718-24. [NERC ID #22537]
Tanguy B, Pothier Venturini AC, Rida Z, Mascarel P, Paratian N, Baumont G, Delambre JF, Rahoelina B, Zaidou A. 1999. Study of 162 cases of bronchogenic carcinoma hospitalized in a pneumology department of an overseas regional hospital from 1991 to 1997. Revue des Maladies Respiratoires 16(1 Suppl):1S98. In French. [NERC ID #22841]
Takigawa N, Segawa Y, Nakata M, Saeki H, Mandai K, Kishino D, Shimono M, Ida M, Eguchi K. 1999. Clinical investigation of atypical adenomatous hyperplasia of the lung. Lung Cancer 25(2):115-21. [NERC ID #23208]
Szyfter K, Szmeja Z, Szyfter W, Hemminki K, Banaszewski J, JaskuLa-Sztul R, Louhelainen J. 1999. Molecular and cellular alterations in tobacco smoke-associated larynx cancer. Mutat Res 445(2):259-74. [NERC ID #23862]
Szyfter K, Banaszewski J, JaLoszynski P, Pabiszczak M, Szyfter W, Szmeja Z. 1999. Carcinogen: DNA adducts in tobacco smoke-associated cancer of the upper respiratory tract. Acta Biochim Pol 46(2):275-87. [NERC ID #23765]
Szadkowska-Stanczyk I, Szymczak W. 1999. [The causes of increased risk for lung cancer in the pulp and paper industry workers. The effect of smoking and exposure to chemicals] Przyczyny podwy.ANG.zszonego ryzyka raka pLuca wsrod pracownikow przemysLu celulozowo-papierniczego. Rola palenia tytoniu oraz ekspozycji na czynniki chemiczne. Med Pr 50(1):3-14. In Polish, summary English. [NERC ID #22857]
Stucker I, de Waziers I, Cenee S, Bignon J, Depierre A, Milleron B, Beaune P, Hemon D. 1999. GSTM1, smoking and lung cancer: A case-control study. International Journal of Epidemiology 28(5):829-835. [NERC ID #24307]
Strauss G, Dominioni L. 1999. Varese meeting report. Lung Cancer 23(2):171-2. [NERC ID #22555]
Stoebner-Delbarre A, Epidaure CRLC. 1999. [Analytic epidemiology: risk factors in France] Epidemiologie analytique: les facteurs de risque en France. Rev Mal Respir 16(Suppl 3):S45-6. In French. [NERC ID #22536]
Stieber P, Dienemann H, Schalhorn A, Schmitt UM, Reinmiedl J, Hofmann K, Yamaguchi K. 1999. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas. Anticancer Res 19(4A):2673-8. [NERC ID #23075]
Spitz MR, Wei Q, Li G, Wu X. 1999. Genetic susceptibility to tobacco carcinogenesis [see comments]. Cancer Invest 17(8):645-59. [NERC ID #23887]
Soldan M, Nagel G, Losekam M, Ernst M, Maser E. 1999. Interindividual variability in the expression and NNK carbonyl reductase activity of 11beta-hydroxysteroid dehydrogenase 1 in human lung. Cancer Lett 145(1-2):49-56. [NERC ID #23807]
Shkolnikov V, McKee M, Leon D, Chenet L. 1999. Why is the death rate from lung cancer falling in the Russian Federation? EurJ Epidemiol 15(3):203-6. [NERC ID #23796]
Shigematsu H, Shigematsu K. 1999. Factors affecting the long-term outcome of Buerger's disease (thromboangiitis obliterans). Int Angiol 18(1):58-64. [NERC ID #23006]
Shaw GL. 1999. Additional clues to lung cancer risk [editorial; comment]. Cancer Invest 17(8):661-2. [NERC ID #23886]
Sekine I, Nishiwaki Y, Yokose T, Nagai K, Suzuki K, Kodama T. 1999. Young lung cancer patients in Japan: different characteristics between the sexes. Ann Thorac Surg 67(5):1451-5. [NERC ID #22724]
Sekine I, Nagai K, Tsugane S, Yokose T, Kodama T, Nishiwaki Y, Suzuki K, Kuriyama T. 1999. Association between smoking and tumor progression in Japanese women with adenocarcinoma of the lung. Jpn J Cancer Res 90(2):129-35. [NERC ID #22052]
Schreiber G, Pitterle D, Kim YC, Bepler G. 1999. Molecular genetic analysis of primary lung cancer and cancer metastatic to the lung. Anticancer Res 19(2A):1109-15. [NERC ID #22726]
Schneider J, Presek P, Braun A, Bauer P, Konietzko N, Wiesner B, Woitowitz H-J. 1999. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer. British Journal of Cancer 80(12):1987-1994. [NERC ID #23161]
Saverin R, Braunlich A, Dahmann D, Enderlein G, Heuchert G. 1999. Diesel exhaust and lung cancer mortality in potash mining. Am J Ind Med 36(4):415-22. [NERC ID #23192]
Satcher D. 1999. Cigars and public health [editorial; comment] N Engl J Med 340(23):1829-31. [NERC ID #22550]
Sastre MTM, Mullet E, Sorum PC. 1999. Relationship between ciggrette dose and perceived risk of lung cancer. Preventive Medicine 28(6):566-571. [NERC ID #22830]
Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, Rea F, Cavallesco G, Tropeano G, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM. 1999. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160(2):711-7. [NERC ID #23017]
Rusin M, Butkiewicz D, Malusecka E, Zborek A, Harasim J, Czyzewski K, Bennett WP, Shields PG, Weston A, Welsh JA, Krzyzowska-Gruca S, Chorazy M, Harris CC. 1999. Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland. Br J Cancer 80(9):1445-52. [NERC ID #22870]
Rowland RE, Harding KM. 1999. Increased sister chromatid exchange in the peripheral blood lymphocytes of young women who smoke cigarettes. Hereditas (Lund) 131(2):143-146. [NERC ID #25198]
Riantawan P, Tungsagunwattana S, Subhannachart P, Yodtasurodom C. 1999. Histologic types, staging, resectability, and smoking among Thai patients with lung cancer. J Med Assoc Thai 82(2):121-5. [NERC ID #22049]
Reif AE, Heeren T. 1999. Consensus on synergism between cigarette smoke and other environmental carcinogens in the causation of lung cancer. Advances in Cancer Research 76:161-86. [NERC ID #22548]
Reddy S, Nyugen HG, Cross CE, van der Vliet A. 1999. Identification of oxidative modifications of glutathione by cigarette smoke. Free Radical Biology & Medicine 27(Suppl 1):S127. [NERC ID #24297]
Rapiti E, Jindal SK, Gupta D, Boffetta P. 1999. Passive smoking and lung cancer in Chandigarh, India. Lung Cancer 23(3):183-9. [NERC ID #23089]
Ralhan R, Swain RK, Agarwal S, Kaur J, Nath N, Sarkar G, Mathur M, Shukla NK. 1999. P-glycoprotein is positively correlated with p53 in human oral pre-malignant and malignant lesions and is associated with poor prognosis. Int J Cancer 84(1):80-5. [NERC ID #22257]
Powell CA, Klares S, O'Connor G, Brody JS. 1999. Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer. Clin Cancer Res 5(8):2025-34. [NERC ID #23801]
Patterson GA, Campbell DB. 1999. Clinical-Pathologic Conference in Thoracic Surgery: T1 N1 stage IIA adenocarcinoma [clinical conference]. J Thorac Cardiovasc Surg 118(1):201-6. [NERC ID #22780]
Parekh K, Rusch V, Kris M. 1999. The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia. Cancer 86(9):1720-3. [NERC ID #23838]
Paolini M, Cantelli-Forti G, Perocco P, Pedulli GF, Abdel-Rahman SZ, Legator MS. 1999. Co-carcinogenic effect of beta-carotene [letter] Nature 398(6730):760-1. [NERC ID #22565]
Pandey M, Mathew A, Nair MK. 1999. Global perspective of tobacco habits and lung cancer: a lesson for third world countries. Eur J Cancer Prev 8(4):271-9. [NERC ID #23248]
Okubo K, Mark EJ, Flieder D, Wain JC, Wright CD, Moncure AC, Grillo HC, Mathisen DJ. 1999. Bronchoalveolar carcinoma: clinical, radiologic, and pathologic factors and survival. J Thorac Cardiovasc Surg 118(4):702-9. [NERC ID #23864]
Okamoto N, Suzuki T, Hasegawa H, Gotoh T, Hagiwara S, Sekimoto M, Kaneko M. 1999. Evaluation of a clinic-based screening program for lung cancer with a case-control design in Kanagawa, Japan. Lung Cancer 25(2):77-85. [NERC ID #23207]
O'Donnell PN, Barber PV, Margison GP, Povey AC. 1999. Association between O6-alkylguanine-DNA-alkyltransferase activity in peripheral blood lymphocytes and bronchial epithelial cells. Cancer Epidemiol Biomarkers Prev 8(7):641-5. [NERC ID #23090]
Nelson HH, Christiani DC, Wiencke JK, Mark EJ, Wain JC, Kelsey KT. 1999. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis. Cancer Res 59(18):4570-3. [NERC ID #23221]
Murin S. 1999. Cigarette smoking and the risk of pulmonary metastases from breast cancer. Journal of Investigative Medicine 47(2):36A. [NERC ID #21961]
Moore MA, Kunimoto T, Park CB, Tsuda H. 1999. Cross-country comparisons suggest shared risk factors for carcinomas, including male lung adenocarcinoma and colon cancer development. Lung Cancer 24(3):149-55. [NERC ID #23088]
Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A. 1999. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 59(14):3317-20. [NERC ID #22883]
Miyake M, Adachi M, Huang C, Higashiyama M, Kodama K, Taki T. 1999. A novel molecular staging protocol for non-small cell lung cancer. Oncogene 18(14):2397-404. [NERC ID #22538]
Mendenhall WM, Million RR, Stringer SP, Cassisi NJ. 1999. Squamous cell carcinoma of the glottic larynx: a review emphasizing the University of Florida philosophy. South Med J 92(4):385-93. [NERC ID #22521]
McVie JG. 1999. Intervention studies on cancer. European Journal of Cancer Prevention 8(5):377-8, discussion 379-80. [NERC ID #23899]
McGuirt WF, Ray M. 1999. Second laryngeal cancers in previously treated larynges. Laryngoscope 109(9):1406-8. [NERC ID #23213]
McDuffe HH, Pahwa P, Robson D. 1999. Brillant hypothesis, conflicting evidence. Proceedings of the American Association for Cancer Research Annual Meeting. 40:246. [NERC ID #22401]
Mazza A, Casiglia E, Scarpa R, Tikhonoff V, Pizziol A, Sica E, Pessina AC. 1999. Predictors of cancer mortality in elderly subjects. Eur J Epidemiol 15(5):421-7. [NERC ID #23051]
Matthias C, Jahnke V, Hand P, Fryer AA, Strange RC. 1999. [Immunohistologic and molecular genetic studies of the effect of glutathione-S-transferases on the development of squamous epithelial carcinomas in the area of the head-neck] Immunhistochemische und molekulargenetische Untersuchungen zum Einfluss von Glutathion-S-Transferasen auf die Entwicklung von Plattenepithelkarzinomen im Kopf-Hals-Bereich. Laryngorhinootologie 78(4):182-8. In German, summary English. [NERC ID #23023]
Maser E. 1999. The protective role of 11 beta-hydroxysteroid dehydrogenase/carbonyl reductase against tobacco-smoke related lung cancer. Adv Exp Med Biol 463:379-87. [NERC ID #22875]
Martinez ME, Marshall JR, Einspahr J, Reid ME, Sampliner R, Maltzman T, Ahnen D, Ambrosone CB, Thompson P, Kadlubar FF, Alberts DS. 1999. Cigarette smoking, N-acetyltransferase 2, and Ki-ras mutations in adenomatous polyps. Proceedings of the American Association for Cancer Research Annual Meeting, 90th. 40:242-243. [NERC ID #22404]
Marcus PM, Prorok PC. 1999. Reanalysis of the Mayo Lung Project data: the impact of confounding and effect modification. J Med Screen 6(1):47-9. [NERC ID #22735]
Marchetti D(a). 1999. Prevention of bronchogenic carcinoma: The battle against cigarette smoking: Information and disinformation: Repercussions on the major public health problems. Revue des Maladies Respiratoires 16(Suppl 3):3S193-3S194. In French. [NERC ID #22965]
Malusecka E, Zborek A, Krzyzowska-Gruca S. 1999. Changes in expression of pRb, p16 and cyclin D1 in non-small cell lung cancer: an immunohistochemical study. Folia Histochem Cytobiol 37(1):19-24. [NERC ID #22516]
Malara NM, Sgambato A, Granone P, Flamini G, Margaritora S, Boninsegna A, Cesario A, Galetta D, Yang Q, Cittadini A. 1999. Biological characterization of central and peripheral primary non small cell lung cancers (NSCLC). Anticancer Res 19(3B):2249-52. [NERC ID #23045]
Lubin JH. 1999. Estimating Lung Cancer Risk with Exposure to Environmental Tobacco Smoke. Environ Health Perspec Supplements 107(6):879-83. [NERC ID #27527]
Lotan R. 1999. Lung cancer promotion by beta-carotene and tobacco smoke: relationship to suppression of retinoic acid receptor-beta and increased activator protein-1? [editorial; comment]. J Natl Cancer Inst 91(1):7-9. [NERC ID #21102]
Lopez AD. 1999. Measuring the health hazards of tobacco: commentary. Bull World Health Organ 77(1):82-3. [NERC ID #22065]
Lin P, Wang HJ, Lee H, Lee HS, Wang SL, Hsueh YM, Tsai KJ, Chen CY. 1999. NAD(P)H: quinone oxidoreductase polymorphism and lung cancer in Taiwan. J Toxicol Environ Health 58(4):187-97. [NERC ID #23870]
Lilly-Tariah OB, Ukoli CO, Nwana EJ. 1999. Cancer of the larynx in black Africans in Jos Nigeria. Cent Afr J Med 45(2):40-2. [NERC ID #23071]
Levi F, Randimbison L, Te VC, La Vecchia C. 1999. Second primary cancers in patients with lung carcinoma. Cancer 86(1):186-90. [NERC ID #22767]
Levi F, La Vecchia C, Lucchini F, Negri E. 1999. Lung cancer in Icelandic women [letter]. Eur J Cancer Prev 8(4):369. [NERC ID #23246]
Leppala JM, Virtamo J, Heinonen OP. 1999. Validation of stroke diagnosis in the National Hospital Discharge Register and the Register of Causes of Death in Finland. Eur J Epidemiol 15(2):155-60. [NERC ID #23393]
Leonard CT, Sachs DP. 1999. Environmental tobacco smoke and lung cancer incidence. Curr Opin Pulm Med 5(4):189-93. [NERC ID #23055]
Leenhouts HP. 1999. Radon-induced lung cancer in smokers and non-smokers: risk implications using a two-mutation carcinogenesis model. Radiat Environ Biophys 38(1):7-71. [NERC ID #22980]
Lee PN. 1999. Simple methods for checking for possible errors in reported odds ratios, relative risks and confidence intervals. Stat Med 18(15):1973-81. [NERC ID #23230]
Lee I-M, Sesso HD, Paffenbarger RS Jr. 1999. Physical activity and risk of lung cancer. International Journal of Epidemiology 28(4):620-625. [NERC ID #23154]
Lee HC, Lim ML, Lu CY, Liu VW, Fahn HJ, Zhang C, Nagley P, Wei YH. 1999. Concurrent increase of oxidative DNA damage and lipid peroxidation together with mitochondrial DNA mutation in human lung tissues during aging--smoking enhances oxidative stress on the aged tissues. Arch Biochem Biophys 362(2):309-16. [NERC ID #22135]
Le Houezec J. 1999. Prevention of bronchogenic carcinoma: The battle against cigarette smoking: Availability of nicotine replacement products and cancer prevention. Revue des Maladies Respiratoires 16(Suppl 3):3S194-3S195. In French. [NERC ID #22966]
Kunitoh H, Sekine I, Kubota K, Tamura T, Shinkai T, Kodama T, Saijo N, Naruke T, Yamaguchi N. 1999. Histologic types of lung carcinoma and related family history of anatomic sites and histologic types of cancers. Cancer 86(7):1182-8. [NERC ID #23242]
Kubina M, Hedelin G, Charloux A, Purohit A, Pauli G, Quoix E. 1999. [Do patients with squamous cell carcinoma or adenocarcinoma of the lung have different smoking histories?] Les patients ayant un carcinome malpighien et ceux ayant un adenocarcinome bronchique ont-ils une histoire tabagique differente? Rev Mal Respir 16(4):539-49. In French, summary English. [NERC ID #23856]
Kubik A, Zatloukal P, Kriz J. 1999. [Trends in lung cancer mortality in the Czech Republic 1950-1995 and predictions up to the year 2009] Vyvoj umrtnosti na plicni rakovinu v Ceske republice v letech 1950-1995 a predikce do roku 2009. Cas Lek Cesk 138(10):310-5. In Czech, summary English. [NERC ID #22911]
Kreuzer M, Pohlabeln H, Ahrens W, Kreienbrock L, Bruske-Hohlfeld I, Jockel KH, Wichmann HE. 1999. Occupational risk factors for lung cancer among young men. Scand J Work Environ Health 25(5):422-9. [NERC ID #23854]
Kreuzer M, Kreienbrock L, Muller KM, Gerken M, Wichmann E. 1999. Histologic types of lung carcinoma and age at onset. Cancer 85(9):1958-65. [NERC ID #22529]
Kilicarslan B, Karpuzoglu G. 1999. p53 expression in non small cell lung and small lung carcinomas: relationship with proliferating cell nuclear antigen and cigarette smoking. Virchows Archiv 435(3):287. [NERC ID #23359]
Kihara M, Kihara M, Noda K. 1999. Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Cancer Lett 137(1):53-60. [NERC ID #22751]
Katoh T, Kaneko S, Takasawa S, Nagata N, Inatomi H, Ikemura K, Itoh H, Matsumoto T, Kawamoto T, Bell DA. 1999. Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 9(2):165-9. [NERC ID #22788]
Jourenkova-Mironova N, Voho A, Bouchardy C, Wikman H, Dayer P, Benhamou S, Hirvonen A. 1999. Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk. Cancer Epidemiol Biomarkers Prev 8(2):185-8. [NERC ID #22485]
Jahn I, Ahrens W, Bruske-Hohlfeld I, Kreuzer M, Mohner M, Pohlabeln H, Wichmann HE, Jockel KH. 1999. Occupational risk factors for lung cancer in women: results of a case-control study in Germany. Am J Ind Med 36(1):90-100. [NERC ID #23046]
Jacobs DR Jr, Adachi H, Mulder I, Kromhout D, Menotti A, Nissinen A, Blackburn H. 1999. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med 159(7):733-40. [NERC ID #22487]
Jaakkola MS, Samet JM. 1999. Summary: Workshop on Health Risks Attributable to ETS Exposure in the Workplace. Environ Health Perspec Supplements 107(6):823-7. [NERC ID #27536]
Iribarren C, Tekawa IS, Sidney S, Friedman GD. 1999. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men [see comments] N Engl J Med 340(23):1773-80. [NERC ID #22551]
Inoue K. 1999. Japan's tobacco tragedy [letter]. Nat Med 5(10):1091. [NERC ID #23245]
Hwang S, Mims BM, Lozano G, Strong LC. 1999. Impact of smoking habit and germline p53 mutation on cancer risk. American Journal of Human Genetics 65(4):A131. [NERC ID #23363]
Hussain SP, Harris CC. 1999. p53 mutation spectrum and load: The generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutation Research 428(1-2):23-32. [NERC ID #23338]
Husgafvel-Pursiainen K, Karjalainen A, Kannio A, Anttila S, Partanen T, Ojajarvi A, Vainio H. 1999. Lung cancer and past occupational exposure to asbestos. Role of p53 and K-ras mutations. Am J Respir Cell Mol Biol 20(4):667-74. [NERC ID #22517]
Hou SM, Yang K, Nyberg F, Hemminki K, Pershagen G, Lambert B. 1999. Hprt mutant frequency and aromatic DNA adduct level in non-smoking and smoking lung cancer patients and population controls. Carcinogenesis 20(3):437-44. [NERC ID #22063]
Hong WK. 1999. Chemoprevention of lung cancer. Oncology 13(10 Suppl 5):135-41. [NERC ID #23827]
Hittelman WN. 1999. Clones and subclones in the lung cancer field [editorial; comment] J Natl Cancer Inst 91(21):1796-9. [NERC ID #23874]
Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP. 1999. Early Lung Cancer Action Project: overall design and findings from baseline screening [see comments]. Lancet 354(9173):99-105. [NERC ID #22858]
Henning S, Cascorbi I, Munchow B, Jahnke V, Roots I. 1999. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk. Pharmacogenetics 9(1):103-11. [NERC ID #22544]
Hecht SS. 1999. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91(14):1194-210. [NERC ID #22895]
Gritz ER, Carmack CL, de Moor C, Coscarelli A, Schacherer CW, Meyers EG, Abemayor E. 1999. First year after head and neck cancer: quality of life. J Clin Oncol 17(1):352-60. [NERC ID #23033]
Gori GB. 1999. Environmental tobacco smoke and lung cancer among nonsmokers [letter] Epidemiology 10(1):95-6. [NERC ID #22218]
Glaser JH. 1999. Re: Early age at smoking initiation and tobacco carcinogen DNA damage in the lung [letter]. J Natl Cancer Inst 91(16):1423. [NERC ID #23032]
Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P. 1999. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Cancer Epidemiol Biomarkers Prev 8(4 Pt 1):297-302. [NERC ID #22583]
Garipagaoglu M, Munley MT, Hollis D, Poulson JM, Bentel GC, Sibley G, Anscher MS, Fan M, Jaszczak RJ, Coleman RE, Marks LB. 1999. The effect of patient-specific factors on radiation-induced regional lung injury. Int J Radiat Oncol Biol Phys 45(2):331-8. [NERC ID #23200]
Fujita T, Kiyama M, Tomizawa Y, Kohno T, Yokota J. 1999. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes. Int J Oncol 15(5):927-34. [NERC ID #23837]
Franceschi S, Bidoli E. 1999. The epidemiology of lung cancer. Ann Oncol 10(Suppl 5):S3-6. [NERC ID #28064]
Fracchia A, Ubbiali A, El Bitar O, Pacetti M, Sommariva E, Arreghini M, Longhini E, Bonalumi GP. 1999. A comparative study on ferritin concentration in serum and bilateral bronchoalveolar lavage fluid of patients with peripheral lung cancer versus control subjects. Oncology 56(3):181-8. [NERC ID #22522]
Erren TC, Jacobsen M, Piekarski C. 1999. Synergy between asbestos and smoking on lung cancer risks. Epidemiology 10(4):405-11. [NERC ID #22917]
Ellison MD, Campbell BH. 1999. Screening for cancers of the head and neck: addressing the problem. Surg Oncol Clin N Am 8(4):725-34, vii. [NERC ID #23816]
Duffaud F,Orsiere T,Digue L,Villani P, Volot F, Favre R, Botta A. 1999. Micronucleated lymphocyte rates from head-and-neck cancer patients. Mutat Res 439(2):259-66. [NERC ID #22093]
Droste JH, Weyler JJ, Van Meerbeeck JP, Vermeire PA, van Sprundel MP. 1999. Occupational risk factors of lung cancer: a hospital based case-control study. Occup Environ Med 56(5):322-7. [NERC ID #23072]
Doll R, Hill AB. 1999. Smoking and carcinoma of the lung. Preliminary report. 1950 [classical article].Bull World Health Organ 77(1):84-93. [NERC ID #22064]
Devesa SS, Grauman DJ, Blot WJ, Fraumeni JF Jr. 1999. Cancer surveillance series: Changing geographic patterns of lung cancer mortality in the United States, 1950 through 1994. Journal of the National Cancer Institute (Bethesda) 91(12):1040-1050. [NERC ID #22820]
Decker PA, Doffek KM, Demeure MJ, Chow JT, Sidransky D, Ahrendt SA. 1999. Cigarette smoking is associated with chromosome 9p21 loss in non-small cell lung cancer. Proceedings of the American Association for Cancer Research Annual Meeting. 40:187. [NERC ID #22411]
de Perrot M, Licker M, Robert J, Spiliopoulos A. 1999. Time trend in the surgical management of patients with lung carcinoma. Eur J Cardiothorac Surg 15(4):433-7. [NERC ID #22801]
Cholerton S, Boustead C, Wilson M, Willits I, Idle JR. 1999. A pilot study of the effects of cigarette smoking and CYP2D6 genotype on DNA strand breakage. NATO ASI Series A Life Sciences; Advances in DNA damage and repair: Oxygen radical effects, cellular protection, and biological consequences. AZ Dordrecht, The Netherlands: Kluwer Academic Publishers. p. 302 450-451. [NERC ID #22958]
Chiang CP, Huang JS, Wang JT, Liu BY, Kuo YS, Hahn LJ, Kuo MY. 1999. Expression of p53 protein correlates with decreased survival in patients with areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 28(2):72-6. [NERC ID #22145]
Cheng Y-J, Hildesheim A, Hsu M-M, Chen I-H, Brinton Louise A, Levine PH, Chen C-J, Yang C-S. 1999. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes & Control 10(3):201-207. [NERC ID #22948]
Chatzis C, Danaka G, Linos A, Kales SN, Christiani DC. 1999. Lung cancer and occupational risk factors in Greece. J Occup Environ Med 41(1):29-35. [NERC ID #22115]
Chailleux E. 1999. Pollution and respiratory health: Pollution and bronchogenic carcinoma. Revue des Maladies Respiratoires 16(Suppl 3):3S184. In French. [NERC ID #22963]
Castren O. 1999. Implications of a two-stage clonal expansion model to indoor radon risk assessment. Health Phys 76(4):393-7. [NERC ID #22472]
Castelli E, Hrelia P, Maffei F, Fimognari C, Foschi FG, Caputo F, Cantelli-Forti G, Stefanini GF, Gasbarrini G. 1999. Indicators of genetic damage in alcoholics: reversibility after alcohol abstinence. Hepatogastroenterology 46(27):1664-8. [NERC ID #23065]
Cartman ML, Muers MF. 1999. Rising incidence of SCLC in young women [letter]. Thorax 54(7):656. [NERC ID #22851]
Carrion Valero F, Jimenez Ruiz CA. 1999. [Passive smoking in childhood] El tabaquismo pasivo en la infancia. Arch Bronconeumol 35(1):39-47. In Spanish. [NERC ID #22156]
Carpenter CL, London SJ. 1999. Lung cancer risk associated with family histories of smoking and lung cancer. American Journal of Human Genetics 65(4):A120. [NERC ID #23364]
Carpenter CL, Jarvik ME, Morgenstern H, McCarthy WJ, London SJ. 1999. Mentholated cigarette smoking and lung-cancer risk. Annals of Epidemiology 9(2):114-120. [NERC ID #22375]
Carmella SG, Ye M, Upadhyaya P, Hecht SS. 1999. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine. Cancer Res 59(15):3602-5. [NERC ID #23040]
Butkiewicz D, Cole KJ, Phillips DH, Harris CC, Chorazy M. 1999. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels. Eur J Cancer Prev 8(4):315-23. [NERC ID #23247]
Bruske-Hohlfeld I, Mohner M, Ahrens W, Pohlabeln H, Heinrich J, Kreuzer M, Jockel KH, Wichmann HE. 1999. Lung cancer risk in male workers occupationally exposed to diesel motor emissions in Germany. Am J Ind Med 36(4):405-14. [NERC ID #23193]
Brown KG. 1999. Lung Cancer and Environmental Tobacco Smoke: Occupational Risk to Nonsmokers. Environ Health Perspec Supplements 107(6):885(6). [NERC ID #27526]
Bradna J. 1999. [Determination of tobacco mosaic viruses and tar carcinogens using electromagnetic resonance in smokers] Sledovani viru tabakove mozaiky a dehtovych kancerogen.ANG.u u kurak.ANG.u elektromagnetickou rezonanci. Epidemiol Mikrobiol Imunol 48(2):71-5. In Czech, summary English. [NERC ID #22736]
Bono R, Vincenti M, Meineri V, Pignata C, Saglia U, Giachino O, Scursatone E. 1999. Formation of N-(2-hydroxyethyl)valine due to exposure to ethylene oxide via tobacco smoke: A risk factor for onset of cancer. Environ Res 81(1):62-71. [NERC ID #22747]
Bonn D. 1999. More warnings given to teenage smokers. Lancet (North American Edition) 353(9161):1333. [NERC ID #22379]
Boffetta P, Pershagen G, Jockel KH, Forastiere F, Gaborieau V, Heinrich J, Jahn I, Kreuzer M, Merletti F, Nyberg F, Rosch F, Simonato L. 1999. Cigar and pipe smoking and lung cancer risk: a multicenter study from Europe [see comments]. J Natl Cancer Inst 91(8):697-701. [NERC ID #22497]
Boffetta P, Ahrens W, Nyberg F, Mukeria A, Bruske-Hohlfeld I, Fortes C, Constantinescu V, Simonato L, Batura-Gabryel H, Lea S, Gaborieau V, Benhamou S. 1999. Exposure to environmental tobacco smoke and risk of adenocarcinoma of the lung. Int J Cancer 83(5):635-9. [NERC ID #23790]
Bianchi C, Brollo A, Ramani L, Zuch C. 1999. Asbestos exposure in lung carcinoma: a necropsy-based study of 414 cases. Am J Ind Med 36(3):360-4. [NERC ID #23076]
Bergqvist M, Brattstrom D, Hesselius P, Wiklund B, Silen A, Wagenius G, Brodin O. 1999. Cytokeratin 8 and 18 fragments measured in serum and their relation to survival in patients with non-small cell lung cancer. Anticancer Res 19(3A):1833-6. [NERC ID #23056]
Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Shields PG, Harris CC. 1999. Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J Pathol 187(1):8-18. [NERC ID #22539]
Bennett WP, Alavanja MC, Blomeke B, Vahakangas KH, Castren K, Welsh JA, Bowman ED, Khan MA, Flieder DB, Harris CC. 1999. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women [see comments]. J Natl Cancer Inst 91(23):2009-14. [NERC ID #23871]
Benichou J. 1999. [Epidemiology of precancerous lesions: from endoscopic detection to screening] Epidemiologie des lesions pre-cancereuses: de la detection endoscopique au depistage. Rev Mal Respir 16(Suppl 3):S46-7. In French. [NERC ID #22535]
Auliac JB, Bota S, Paris C, Lacolomberie F, Helot MF, Sauget F, Metayer J, Nouvet G, Thiberville L. 1999. Serum levels of vitamins A, E, beta carotene, and selenium in a population at high risk for developing lung cancer. Revue des Maladies Respiratoires. 16(1 Suppl):1S77. In French. [NERC ID #22842]
Au WW, Sierra-Torres CH, Cajas-Salazar N, Salama SA. 1999. Inheritance of polymorphic metabolizing genes on environmental disease and quality of life. Mutat Res 428(1-2):131-40. [NERC ID #23779]
Arnould JP, Pfohl-Leszkowicz A, Bach V, Libert JP, Belegaud J. 1999. Biological monitoring exposure of workers from plant producing carbon electrodes: quantification of benzo[a]pyrene DNA-adducts in leukocytes, by a 32P-postlabelling method and an immunoassay. Hum Exp Toxicol 18(5):314-21. [NERC ID #22800]
Armadans-Gil L, Vaque-Rafart J, Rossello J, Olona M, Alseda M. 1999. Cigarette smoking and male lung cancer risk with special regard to type of tobacco. International Journal of Epidemiology 28(4):614-619. [NERC ID #23155]
Andre F, Jacot W, Pujol JL, Grunenwald D, Le Chevalier T. 1999. [Epidemiology, prognostic factors, staging, and treatment of non-small cell lung cancer] Epidemiologie, facteurs pronostiques, bilan d'extension et traitement des cancers bronchiques non a petites cellules. Bull Cancer (Suppl 3):17-41. In French, summary English. [NERC ID #23902]
Albin M, Magnani C, Krstev S, Rapiti E, Shefer I. 1999. Asbestos and cancer: An overview of current trends in Europe. Environ Health Perspect 107(Suppl 2):289-98. [NERC ID #22578]
Adjei AA, Marks RS, Bonner JA. 1999. Current guidelines for the management of small cell lung cancer. Mayo Clinic Proceedings 74(8):809-816. [NERC ID #22944]
Achiwa H, Yatabe Y, Hida T, Kuroishi T, Kozaki K, Nakamura S, Ogawa M, Sugiura T, Mitsudomi T, Takahashi T. 1999. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res 5(5):1001-5. [NERC ID #22867]
[Anonymous]. 1999. Cigars and health: the National Cancer Institute reports. Harv Mens Health Watch 3(8):4-5. [NERC ID #22129]
Zhou J, Mulshine JL, Ro JY, Avis I, Yu R, Lee JJ, Morice R, Lippman SM, Lee JS. 1998. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clin Cancer Res 4(7):1631-40. [NERC ID #6401]
Zaridze D, Maximovitch D, Zemlyanaya G, Aitakov Z, Boffetta P. 1998. Exposure to environmental tobacco smoke and risk of lung cancer in non-smoking women from Moscow, Russia. International Journal of Cancer 75(3):335-338. [NERC ID #1601]
Zang EA, Wynder EL. 1998. Alcohol consumption and lung cancer risk. A study in confounding. 31st Annual Meeting of the Society for Epidemiologic Research, June 24-26, 1998, Chicago, Illinois, USA. American Journal of Epidemiology 147(11 Suppl):S60. [NERC ID #9902]
Xia H, Carlin BP. 1998. Spatio-temporal models with errors in covariates: mapping Ohio lung cancer mortality. Stat Med 17(18):2025-43. [NERC ID #21320]
Wynder EL. 1998. The past, present, and future of the prevention of lung cancer. Cancer Epidemiol Biomarkers Prev 7(9):735-48. [NERC ID #21726]
Wynder EL, Hoffmann D. 1998. Re: Cigarette smoking and the histopathology of lung cancer [letter]. J Natl Cancer Inst 90(19):1486-8. [NERC ID #21615]
Wunsch-Filho V, Moncau JE, Mirabelli D, Boffetta P. 1998. Occupational risk factors of lung cancer in Sao Paulo, Brazil. Scand J Work Environ Health 24(2):118-24. [NERC ID #6184]
Wu X, Zhao Y, Kemp BL, Amos CI, Siciliano MJ, Spitz MR. 1998. Chromosome 5 aberrations and genetic predisposition to lung cancer. Int J Cancer 79(5):490-3. [NERC ID #20885]
Wu X, Zhao Y, Honn SE, Tomlinson GE, Minna JD, Hong W, Spitz MR. 1998. Benzo(alpha)pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. Cancer Research 58(8):1605-1608. [NERC ID #9646]
Wild CP, Pisani P. 1998. Carcinogen DNA and protein adducts as biomarkers of human exposure in environmental cancer epidemiology. Cancer Detect Prev 22(4):273-83. [NERC ID #6405]
Whyatt RM, Santella RM, Jedrychowski W, Garte SJ, Bell DA, Ottman R, Gladek-Yarborough A, Cosma G, Young TL, Cooper TB, Randall MC, Manchester DK, Perera FP. 1998. Relationship between ambient air pollution and DNA damage in Polish mothers and newborns. Environ Health Perspect 106(Suppl 3):821-6. [NERC ID #6394]
Wersall JP, Eklund G. 1998. The decline of smoking among Swedish men. Int J Epidemiol 27(1):20-6. [NERC ID #3170]
Wells AJ. 1998. Lung cancer from passive smoking at work [see comments]. Am J Public Health 88(7):1025-9. [NERC ID #3264]
Weisburger JH. 1998. Worldwide prevention of cancer and other chronic diseases based on knowledge of mechanisms. Mutat Res 402(1-2):331-7. [NERC ID #6249]
Wang LE, Sturgis EM, Eicher SA, Spitz MR, Hong WK, Wei Q. 1998. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin Cancer Res 4(7):1773-8. [NERC ID #6400]
Wadman M. 1998. Dilemma for journals over tobacco cash [news] Nature 394(6694):609. [NERC ID #6245]
Wabinga HR. 1998. Effects of tobacco smoking on the African continent: analysis of lung cancer incidence rates from population based cancer registries [letter]. East Afr Med J 75(12):730-1. [NERC ID #22128]
Vesoulis Z. 1998. Metastatic laryngeal basaloid squamous cell carcinoma simulating primary small cell carcinoma of the lung on fine needle aspiration lung biopsy. A case report. Acta Cytol 42(3):783-7. [NERC ID #3162]
Vallyathan V, Green F, Ducatman B, Schulte P. 1998. Roles of epidemiology, pathology, molecular biology, and biomarkers in the investigation of occupational lung cancer. J Toxicol Environ Health B Crit Rev 1(2):91-116. [NERC ID #3131]
Vaidya JS, Baum M. 1998. Low-dose spiral computed tomography for lung-cancer screening [letter]. Lancet 352(9123):236, discussion 236-7. [NERC ID #6157]
Tang DL, Rundle A, Warburton D, Santella RM, Tsai WY, Chiamprasert S, Hsu YZ, Perera FP. 1998. Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. Carcinogenesis 19(11):1949-53. [NERC ID #21423]
Takagi Y, Osada H, Ku```roishi T, Mitsudomi T, Kondo M, Niimi T, Saji S, Gazdar AF, Takahashi T, Minna JD, Takahashi T. 1998. P53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking. Br J Cancer 77(10):1568-72. [NERC ID #3147]
Taioli E, Zocchetti C, Garte S. 1998. Models of interaction between metabolic genes and environmental exposure in cancer susceptibility. Environ Health Perspect 106(2):67-70. [NERC ID #22765]
Tager IB. 1998. Outcomes in cohort studies. Epidemiol Rev 20(1):15-28. [NERC ID #21410]
Tagawa M, Murata M, Kimura H. 1998 Jun 5. Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features. Cancer Lett 128(1):93-99. [NERC ID #3132]
Szyfter K, Kruk-Zagajewska A, Szmeja Z, Kozak W, Szyfter W, Kujawski M, Banaszewski J, Wojtowicz J. 1998. [Sex-dependence of larynx susceptibility to tobacco smoke carcinogens. The role of androgen hormones] PLec a podatnosc krtani na dziaLanie czynnikow kancerogennych obecnych w dymie tytoniowym. Rola hormonow androgennych. Otolaryngol Pol 52(2):153-8. [NERC ID #6242]
Sunyer J, Lamarca R, Alonso J. 1998. Smoking after age 65 years and mortality in Barcelona, Spain. Am J Epidemiol 148(6):575-80. [NERC ID #8432]
Sugita M, Izuno T, Kanamri M, Otahara Y, Kasuga H. 1998. Per capita gross national product and summarized odds ratio for epidemiologic studies on the relationship between passive smoking and lung cancer. Tokai J Exp Clin Med 23(5):235-40. [NERC ID #23080]
Sugimura T. 1998. Cancer prevention: past, present, future. Mutation Research 402(1-2):7-14. [NERC ID #6248]
Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S. 1998. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 58(22):5032-7. [NERC ID #21439]
Sokas RK. 1998. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer [letter]. N Engl J Med 339(14):1000, discussion 1001-2. [NERC ID #8441]
Smith BJ, Field RW, Lynch CF. 1998. Residential 222Rn exposure and lung cancer: testing the linear no-threshold theory with ecologic data [see comments]. Health Phys 75(1):11-7. [NERC ID #3137]
Shen XB, Wang GX, Zhou BS. 1998. Relation of exposure to environmental tobacco smoke and pulmonary adenocarcinoma in non-smoking women:a case control study in Nanjing. Oncol Rep 5(5):1221-3. [NERC ID #6453]
Sekine I, Shao GG, Fahey M, Kodama T, Nagai K, Kuriyama T. 1998. What causes p53 mutations in patients with lung cancer? Oncol Rep 5(5):1125-8. [NERC ID #6454]
Sekido Y, Fong KM, Minna JD. 1998. Progress in understanding the molecular pathogenesis of human lung cancer. Biochim Biophys Acta 1378(1):F21-59. [NERC ID #6461]
Schwartz AG, Lassige D, Gillen-Caralli D, Shriver M. 1998. CYP1A1 and CYP2E1 polymorphisms and lung cancer susceptability among nonsmokers. 31st Annual Meeting of the Society for Epidemiologic Research, June 24-26, 1998, Chicago, IL USA. American Journal of Epidemiology 147(11 Suppl):S21. [NERC ID #9905]
Schoket B, Phillips DH, Kostic S, Vincze I. 1998. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients. Carcinogenesis 19(5):841-6. [NERC ID #3140]
Scherer G, Heller WD. 1998. Passive smoking and lung cancer. Risk extrapolation overestimates risk [letter]. BMJ 317(7154):347, discussion 348. [NERC ID #6294]
Sato M, Saito Y, Usuda K, Takahashi S, Sagawa M, Fujimura S. 1998. Occult lung cancer beyond bronchoscopic visibility in sputum-cytology positive patients. Lung Cancer 20(1):17-24. [NERC ID #21710]
Salagovic J,Kalina I, Stubna J, Habalova V, Hrivnak M, Valansky L, Kohut A, Biros E. 1998. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. Neoplasma 45(5):312-7. [NERC ID #21030]
Roy P, Esteve J. 1998. Using relative risk models for estimating synergy between two risk factors. Stat Med 17(12):1357-73. [NERC ID #6482]
Rosengren A, Wilhelmsen L. 1998. Respiratory symptoms and long-term risk of death from cardiovascular disease, cancer and other causes in Swedish men. Int J Epidemiol 27(6):962-9. [NERC ID #22053]
Rosenbaum WL, Sterling TD, Weinkam JJ. 1998. Linear extrapolation models of lung cancer risk associated with exposure to environmental tobacco smoke. Regul Toxicol Pharmacol 28(2):106-14. [NERC ID #22044]